Milan, Italy

Zulma Magnani


 

Average Co-Inventor Count = 7.7

ph-index = 1

Forward Citations = 35(Granted Patents)


Company Filing History:


Years Active: 2018-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Sure, here is an article about inventor Zulma Magnani:

Title: The Innovations of Zulma Magnani in Milan, Italy

Introduction:

Zulma Magnani is a prolific inventor based in Milan, Italy, known for his contributions to the field of T-cell receptor (TCR) and peptides research. With three patents to his name, Zulma Magnani has made significant strides in the field of biotechnology.

Latest Patents:

Zulma Magnani's latest patents include:

1. TCR and Peptides: A T-cell receptor (TCR) that binds to a Wilms tumour 1 protein (WT1) peptide when presented by a major histocompatibility complex (MHC).

2. Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases: Methods and compositions for modifying TCR genes using nucleases (zinc finger nucleases or TAL nucleases) to alter TCR genes.

Career Highlights:

Zulma Magnani has worked with reputable companies such as Ospedale San Raffaele S.r.l. and Sangamo Therapeutics, Inc. His involvement in these organizations has allowed him to further develop his innovative ideas and contribute to the advancement of biotechnology.

Collaborations:

During his career, Zulma Magnani has collaborated with esteemed coworkers such as Maria Chiara Bonini and Philip D. Gregory. These collaborations have been instrumental in the success of his research projects and patent applications.

Conclusion:

In conclusion, Zulma Magnani's work in the field of T-cell receptor (TCR) and peptides research has significantly impacted the biotechnology industry. His patents and collaborations demonstrate his commitment to innovation and pushing the boundaries of scientific discovery.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…